Description:
Technoview®apixabancalibratorset isasetofplasma-derivedcalibration sampleswithapixaban*concentrations rangingfrom~0-500ng/ml. Thesetcanbeusedfor establishingastandardcurveinresearchmeasurementsofapixiban. Itisoptimizedforusewithanti-Xachromogenicassaysand isfrequentlyusedinconjunctionwiththe Technoview®apixabanlowandhighcontrolsinthe Technochrom®anti-Xachromogenicassay.
*ApixabanistheactivesubstanceinEliquis®.
Advantages:
- Allowsforestablishmentof calibrationcurvecoveringarangeof0-500ng/ml
- Optimizedforusewithanti-Xa(withoutexogeneousantithrombin) research assaysbut canvalidated foruseinprothrombintime(PT)researchassays
CalibratorSetComposition:
5x1mlvialswitharangeofapixabanconcentrations:
- Cal1:0ng/ml
- Cal2:50ng/ml
- Cal3:180ng/ml
- Cal4:350ng/ml
- Cal5:500ng/ml
Calibratorsare lyophilizedandpreparedfrompooledhumancitratedplasmasupplementedwithdifferent concentrationsofapixaban.TheplasmacontainsstABIlizersbutnobactericideadditives.Itiscalibrated,usingananti-Xaassay,inng/mlagainstaninternalreferencestandardandinIU/mlagainsttheinternationalstandardforlowmolecularweightheparin(LMWH)inplasma.
Background:
Apixaban(Eliquis®)isanoraldirectfactorXainhibitordrug.Itisprescribedbyahealthcareproviderandcan:
- reducetheriskofbloodclotsandstrokeinindividuals whohavenonvalvularatrialfibrillation;
- treatdeepveinthrombosis(DVT)andpulmonaryembolism(PE);and
- reducetheriskofDVTandPEinindividuals afterhiporkneereplacementsurgery.
Inmostcases,apixabandoesnotrequireroutinemonitoring.IttypicallyprolongsclottingtestssuchasPT/INRandaPTTso,ifnecessary,itisbestmeasuredusingananti-Xachromogenicassay.Note thatthiscalibratorsetisforresearchuseonlyintheUSandCanada.